San Francisco-based biotech startup Loyal says a drug it developed to increase dogs' lifespan "has passed a significant milestone on the way to regulatory approval," reports the Washington Post: The ...
Read moreWe all want our dogs to live forever, don’t we? Possibly the most bittersweet aspect of being a pet parent is knowing that, while we strive to give our animal ...
Read moreBoo, an 11-year-old whippet dog from Pennsylvania, is the very first participant in this clinical trial. Credit: Loyal. A novel treatment may transform the lives of our canine companions but ...
Read more
